Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Dougan

Showing results (11-20 of 275) with videos related to

Pageof 28
Sort By:
Journal of Bacteriology|May 1, 1977
Changes in protein synthesis on mitomycin C induction of wild-type and mutant CloDF13 plasmidsG Dougan, D J Sherratt
Gene|January 1, 1986
Expression of a cloned 987P adhesion-antigen fimbrial determinant in Escherichia coli K-12 strain HB101P M Morrissey, G Dougan
Biotechnology & Genetic Engineering Reviews|January 1, 1984
The impact of new technologies on vaccine developmentM D Winther, G Dougan
Medical Laboratory Sciences|October 1, 1985
DNA probes for microbial diagnosisP E Highfield, G Dougan
Lancet (London, England)|May 21, 1998
Optimism over vaccines administered via mucosal surfacesM M Levine, G Dougan
Infection and Immunity|June 25, 1998
Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor alpha p55 receptorP Everest, M Roberts, G Dougan
Journal of Medical Microbiology|May 1, 1983
Gentamicin and methicillin resistant Staphylococcus aureus in Dublin hospitals: molecular studiesG Dowd, M Cafferkey, G Dougan
Vaccine|October 1, 1996
Delivery of the Pertactin/P.69 polypeptide of Bordetella pertussis using an attenuated Salmonella typhimurium vaccine strain: expression levels and immune responseR Anderson, G Dougan, M Roberts
Nucleic Acids Research|October 25, 1990
Complete nucleotide sequence of the aroA gene from Salmonella typhi encoding 5-enolpyruvylshikimate 3-phosphate synthaseS Chatfield, G Dougan, I Charles
Trends in Biotechnology|December 1, 1993
Phase and antigenic variation--the impact on strategies for bacterial vaccine designD Maskell, G Frankel, G Dougan
Pageof 28

Showing results (11-20 of 275) with videos related to

Sort By:
Pageof 28
Journal of Bacteriology|May 1, 1977
Changes in protein synthesis on mitomycin C induction of wild-type and mutant CloDF13 plasmidsG Dougan, D J Sherratt
Gene|January 1, 1986
Expression of a cloned 987P adhesion-antigen fimbrial determinant in Escherichia coli K-12 strain HB101P M Morrissey, G Dougan
Biotechnology & Genetic Engineering Reviews|January 1, 1984
The impact of new technologies on vaccine developmentM D Winther, G Dougan
Medical Laboratory Sciences|October 1, 1985
DNA probes for microbial diagnosisP E Highfield, G Dougan
Lancet (London, England)|May 21, 1998
Optimism over vaccines administered via mucosal surfacesM M Levine, G Dougan
Infection and Immunity|June 25, 1998
Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor alpha p55 receptorP Everest, M Roberts, G Dougan
Journal of Medical Microbiology|May 1, 1983
Gentamicin and methicillin resistant Staphylococcus aureus in Dublin hospitals: molecular studiesG Dowd, M Cafferkey, G Dougan
Vaccine|October 1, 1996
Delivery of the Pertactin/P.69 polypeptide of Bordetella pertussis using an attenuated Salmonella typhimurium vaccine strain: expression levels and immune responseR Anderson, G Dougan, M Roberts
Nucleic Acids Research|October 25, 1990
Complete nucleotide sequence of the aroA gene from Salmonella typhi encoding 5-enolpyruvylshikimate 3-phosphate synthaseS Chatfield, G Dougan, I Charles
Trends in Biotechnology|December 1, 1993
Phase and antigenic variation--the impact on strategies for bacterial vaccine designD Maskell, G Frankel, G Dougan
Pageof 28